Skip to Main Content

Advertisement

Skip Nav Destination

A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections

J Immunol (2020) 205 (4): 892–898.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal